EdgarLookup

AIBOTICS, INC. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that AIBOTICS, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
-101500.3%
Profit Margin
Net income ÷ revenue
-253.3%
Return on Assets
Net income ÷ assets
-1.22x
Debt-to-Equity
Total liabilities ÷ equity

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.2K Apr 15, 2026
FY2025 Dec 31, 2024 $0 Apr 15, 2026
FY2020 Dec 31, 2020 $0 Apr 15, 2021
FY2020 Dec 31, 2019 $0 Apr 15, 2021
FY2019 Dec 31, 2018 $0 Mar 30, 2020

Gross Profit

Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.2K Apr 15, 2026
FY2025 Dec 31, 2024 $0 Apr 15, 2026
FY2020 Dec 31, 2020 $0 Apr 15, 2021
FY2020 Dec 31, 2019 $0 Apr 15, 2021
FY2019 Dec 31, 2018 $0 Mar 30, 2020

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($2.22M) Apr 15, 2026
FY2025 Dec 31, 2024 ($1.85M) Apr 15, 2026
FY2024 Dec 31, 2023 ($1.18M) Apr 11, 2025
FY2023 Dec 31, 2022 ($2.61M) Apr 23, 2024
FY2022 Dec 31, 2021 ($5.14M) Nov 6, 2023
FY2021 Dec 31, 2020 ($16.0K) Oct 17, 2023

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($1.84M) Apr 15, 2026
FY2025 Dec 31, 2024 ($1.63M) Apr 15, 2026
FY2024 Dec 31, 2023 ($616.7K) Apr 11, 2025
FY2023 Dec 31, 2022 ($1.74M) Apr 23, 2024
FY2022 Dec 31, 2021 ($4.99M) Nov 6, 2023
FY2020 Dec 31, 2020 ($159.4K) Apr 15, 2021
FY2020 Dec 31, 2019 ($251.7K) Apr 15, 2021
FY2019 Dec 31, 2018 ($186.1K) Mar 30, 2020

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($458.2K) Apr 15, 2026
FY2025 Dec 31, 2024 ($259.0K) Apr 15, 2026
FY2024 Dec 31, 2023 ($106.8K) Apr 11, 2025
FY2023 Dec 31, 2022 ($656.6K) Apr 23, 2024
FY2022 Dec 31, 2021 ($235.5K) Nov 6, 2023
FY2021 Dec 31, 2020 ($14.3K) Oct 17, 2023
FY2020 Dec 31, 2019 $98.7K Apr 15, 2021
FY2019 Dec 31, 2018 ($68.5K) Mar 30, 2020

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2022 Dec 31, 2022 $0 Nov 6, 2023
FY2022 Dec 31, 2021 $2.7K Nov 6, 2023
FY2021 Dec 31, 2020 $0 Oct 17, 2023

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $874.7K Apr 15, 2026
FY2025 Dec 31, 2024 $1.46M Apr 15, 2026
FY2024 Dec 31, 2023 $2.22M Apr 11, 2025
FY2023 Dec 31, 2022 $387.4K Apr 23, 2024
FY2022 Dec 31, 2021 $1.27M Nov 6, 2023
FY2021 Dec 31, 2020 $110.7K Oct 17, 2023
FY2020 Dec 31, 2019 $1.22M Apr 15, 2021
FY2019 Dec 31, 2018 $1.50M Mar 30, 2020

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $4.83M Apr 15, 2026
FY2025 Dec 31, 2024 $4.85M Apr 15, 2026
FY2024 Dec 31, 2023 $4.25M Apr 11, 2025
FY2023 Dec 31, 2022 $1.28M Apr 23, 2024
FY2022 Dec 31, 2021 $1.22M Nov 6, 2023
FY2021 Dec 31, 2020 $127.0K Oct 17, 2023
FY2020 Dec 31, 2019 $563.2K Apr 15, 2021
FY2019 Dec 31, 2018 $852.9K Mar 30, 2020

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($3.96M) Apr 15, 2026
FY2025 Dec 31, 2024 ($3.39M) Apr 15, 2026
FY2025 Dec 31, 2023 ($2.03M) Apr 15, 2026
FY2024 Dec 31, 2022 ($891.3K) Apr 11, 2025
FY2023 Dec 31, 2021 $52.0K Apr 23, 2024
FY2022 Dec 31, 2020 ($16.2K) Nov 6, 2023
FY2021 Dec 31, 2019 ($720) Oct 17, 2023
FY2020 Dec 31, 2018 $647.1K Apr 15, 2021
FY2019 Dec 31, 2017 $572.2K Mar 30, 2020

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($13.03M) Apr 15, 2026
FY2025 Dec 31, 2024 ($10.81M) Apr 15, 2026
FY2024 Dec 31, 2023 ($8.96M) Apr 11, 2025
FY2023 Dec 31, 2022 ($7.78M) Apr 23, 2024
FY2022 Dec 31, 2021 ($5.17M) Nov 6, 2023
FY2021 Dec 31, 2020 ($29.2K) Oct 17, 2023
FY2020 Dec 31, 2019 $613.2K Apr 15, 2021
FY2019 Dec 31, 2018 $608.4K Mar 30, 2020

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2021 Dec 31, 2021 $1.27M Apr 14, 2022
FY2021 Dec 31, 2020 $110.7K Apr 14, 2022
FY2021 Dec 31, 2019 $0 Apr 14, 2022
FY2019 Dec 31, 2018 $611.5K Mar 30, 2020

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 486.90M Apr 15, 2026
FY2025 Dec 31, 2024 39.99M Apr 15, 2026
FY2024 Dec 31, 2023 14.90M Apr 11, 2025
FY2023 Dec 31, 2022 14.86M Apr 23, 2024
FY2022 Dec 31, 2021 13.97M Nov 6, 2023
FY2021 Dec 31, 2020 12.93M Oct 17, 2023
FY2020 Dec 31, 2019 12.43M Apr 15, 2021
FY2019 Dec 31, 2018 12.43M Mar 30, 2020